ABVD vs. radiotherapy in early stage Hodgkin's lymphoma A critical look at the NCIC HD.6 trial

被引：0
|
作者：
Wenz, F. [1 ]
Abo-Madyan, Y. [1 ]
Welzel, G. [1 ]
Giordano, F. A. [1 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Mannheim, D-68167 Mannheim, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷 / 08期
关键词：
2ND MALIGNANCIES; DISEASE; CANCER; RADIATION; CHEMOTHERAPY; THERAPY; INTENSITY; NEOPLASMS; LEUKEMIA; COHORT;
D O I：
10.1007/s00066-012-0151-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：649 / 652
页数：4
相关论文
共 50 条
  • [1] ABVD vs. radiotherapy in early stage Hodgkin’s lymphomaA critical look at the NCIC HD.6 trialABVD vs. Strahlentherapie bei Frühstadien des Hodgkin-LymphomsEin kritischer Blick auf die NCIC-HD.6-Studie
    F. Wenz
    Y. Abo-Madyan
    G. Welzel
    F.A. Giordano
    Strahlentherapie und Onkologie, 2012, 188 (8) : 649 - 652
  • [2] Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
    Hira Mian
    Jolie Ringash
    Ralph Meyer
    Annette E. Hay
    Lois Shepherd
    Marina Djurfeldt
    Jane N. Winter
    Jonathan Sussman
    Joseph Pater
    Bingshu E. Chen
    Anca Prica
    Supportive Care in Cancer, 2023, 31
  • [3] Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
    Mian, Hira
    Ringash, Jolie
    Meyer, Ralph
    Hay, Annette E. E.
    Shepherd, Lois
    Djurfeldt, Marina
    Winter, Jane N. N.
    Sussman, Jonathan
    Pater, Joseph
    Chen, Bingshu E. E.
    Prica, Anca
    SUPPORTIVE CARE IN CANCER, 2023, 31 (05)
  • [4] Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial
    Rodriguez-Romo, Laura N.
    Meyer, Ralph
    Pater, Joseph L.
    Sussman, Jonathan
    Zhang, Siwei
    Hongbo, Lui
    Winter, Jane N.
    Vuong, Te
    Blahey, Walter
    Mulroy, Liam
    Shepherd, Lois E.
    Djurfeldt, Marina S.
    Chen, Bingshu E.
    Hay, Annette E.
    BLOOD, 2017, 130
  • [5] Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6
    Meyer, Ralph M.
    Gospodarowicz, Mary
    Connors, Joseph M.
    Pearcey, Robert G.
    Wells, Woodrow A.
    Winter, Jane N.
    Horning, Sandra J.
    Dar, A. Rashid
    Shustik, Chaim
    Stewart, Douglas A.
    Crump, Michael
    Djurfeldt, Marina S.
    Chen, Bingshu E.
    Shepherd, Lois E.
    BLOOD, 2011, 118 (21) : 271 - 272
  • [6] Limited stage nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): A subgroup analysis of the HD.6 clinical trial.
    Monteith, Bethany
    DiMaria, Erica C.
    Crump, Michael
    Ames, Jeffrey B.
    Winter, Jane N.
    Djurfeldt, Marina
    Shepherd, Lois E.
    Meyer, Ralph M.
    Chen, Bingshu E.
    Hay, Annette E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7.
    Sieber, M
    Franklin, J
    Tesch, H
    Rueffer, U
    Brillant, C
    Reineke, T
    Herrmann, R
    Boissevain, F
    Franke, A
    Pfreundschuh, M
    Hossfeld, DK
    Wingbermuehle, K
    Josting, A
    Wolf, J
    Paulus, U
    Mueller, RP
    Duehmke, E
    Engert, A
    Diehl, V
    BLOOD, 2002, 100 (11) : 93A - 93A
  • [8] Relapse patterns and subsequent outcomes of patients treated on the NCICCTG HD.6 (ECOG JHD06) randomized trial evaluating ABVD alone in patients with limited stage Hodgkin lymphoma (HL).
    Macdonald, DA
    Gospodarowicz, MK
    Wells, WA
    Pearcey, RG
    Connors, JM
    Winter, JN
    Horning, SJ
    Djurfeldt, MS
    Ding, KY
    Shepherd, LE
    Meyer, RM
    BLOOD, 2005, 106 (11) : 241A - 241A
  • [9] ABVD vs. COPPEBVCAD (CEC) vs. BEACOPP for the initial treatment of patients with advanced Hodgkin lymphoma(HL). Preliminary results of HD2000 GISL trial
    Federico, M.
    Luminari, S.
    Olio, M. Dell'
    Merli, F.
    Brugiatelli, M.
    Stelitano, C.
    Mammi, C.
    Musso, M.
    Baldini, L.
    Marcheselli, L.
    Gobbi P G, P. G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 34 - 34
  • [10] ABVD chemotherapy without obligatory radiotherapy in patients with early and intermediate stage Hodgkin' lymphoma.
    Naumann, R
    Haenel, A
    Kroschinsky, F
    Beuthien-Baumann, B
    Dawel, M
    Zschuppe, E
    Schmidt, H
    Fiedler, F
    Ehninger, G
    Haenel, M
    BLOOD, 2002, 100 (11) : 302B - 302B
12345